Tag: NTI drugs

Therapeutic Failures: Why Some Generic Drugs Don't Work

Explore why generic drugs sometimes fail and the risks of Narrow Therapeutic Index (NTI) medications, bioequivalence gaps, and manufacturing inconsistencies.

Read More 3 Comments

Multiple Manufacturers: NTI Drugs and Switching Between Generics

NTI drugs like levothyroxine and tacrolimus have a narrow margin between effective and toxic doses. Switching between generic manufacturers can affect blood levels and cause serious side effects-even when FDA-approved. Here's what you need to know.

Read More 11 Comments

Why Generic Switching Raises Concerns for NTI Drugs

Generic substitution for NTI drugs like warfarin and phenytoin can be dangerous due to tiny differences in absorption. Even small changes in blood levels can cause toxicity or treatment failure - making physician approval and close monitoring essential.

Read More 11 Comments